The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles

Biomaterials

Volumn 34, Issue 10, 2013, Pages 2547-2564

  Liu, Chunxi ^a   Liu, Fengxi ^a   Feng, Lixia ^a   Li, Min ^a   Zhang, Jian ^a   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Co delivery; DNA; Double targeting; Doxorubicin; Multifunctional nanoscaled delivery system; Polyion complex micelle

Indexed keywords

CO-DELIVERY; DELIVERY SYSTEMS; DOUBLE TARGETING; DOXORUBICIN; POLYION COMPLEX MICELLES;

ADSORPTION; CELL MEMBRANES; CHEMOTHERAPY; COBALT COMPOUNDS; CYTOLOGY; DNA; ENDOTHELIAL CELLS; MICELLES; NUCLEIC ACIDS; POLYETHYLENE OXIDES; TUMORS; VIRUSES;

POLYETHYLENE GLYCOLS;

AMINO ACID; DNA; DOXORUBICIN; HYDRAZONE DERIVATIVE; MACROGOL; NANOPARTICLE; POLYETHYLENEIMINE; SULFAMERAZINE;

ADSORPTION; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTROSTATIC PRECIPITATION; ENDOSOME; GENE TARGETING; GENE THERAPY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MICELLE; MICROVASCULAR ENDOTHELIAL CELL; PH; PRIORITY JOURNAL; SYNTHESIS;

DNA; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICELLES; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE;

EID: 84872681375     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.12.038     Document Type: Article

References (56)

1. Liu C., Zhang N. Emerging biotechnological strategies for non-viral antiangiogenic gene therapy. Angiogenesis 2012, 15:521-542.
2. Pastorino F., Brignole C., Di Paolo D., Nico B., Pezzolo A., Marimpietri D., et al. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy. Cancer Res 2006, 66:10073-10082.
3. Ma J., Waxman D.J. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther 2008, 7:3670-3684.
4. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004, 56:1649-1659.
5. Kishida T., Asada H., Itokawa Y., Yasutomi K., Shin-Ya M., Gojo S., et al. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol Ther 2003, 8:738-745.
6. Janat-Amsbury M.M., Yockman J.W., Lee M., Kern S., Furgeson D.Y., Bikram M., et al. Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. Mol Ther 2004, 9:829-836.
7. Wang Y., Gao S., Ye W.H., Yoon H.S., Yang Y.Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 2006, 5:791-796.
8. Danhier F., Feron O., Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 2010, 148:135-146.
9. Ma M., Yuan Z.F., Chen X.J., Li F., Zhuo R.X. A facile preparation of novel multifunctional vectors by non-covalent bonds for co-delivery of doxorubicin and gene. Acta Biomater 2012, 8:599-607.
10. Hu Q.D., Fan H., Ping Y., Liang W.Q., Tang G.P., Li J. Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug. Chem Commun (Camb) 2011, 47:5572-5574.
11. Cheng D., Cao N., Chen J., Yu X., Shuai X. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat. Biomaterials 2012, 33:1170-1179.
12. Xiong X.B., Lavasanifar A. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano 2011, 5:5202-5213.
13. Shim G., Han S.E., Yu Y.H., Lee S., Lee H.Y., Kim K., et al. Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug. J Control Release 2011, 155:60-66.
14. Xu Z., Zhang Z., Chen Y., Chen L., Lin L., Li Y. The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model. Biomaterials 2010, 31:916-922.
15. Sun X., Pang Z., Ye H., Qiu B., Guo L., Li J., et al. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Biomaterials 2012, 33:916-924.
16. Liu S., Guo Y., Huang R., Li J., Huang S., Kuang Y., et al. Gene and doxorubicin co-delivery system for targeting therapy of glioma. Biomaterials 2012, 33:4907-4916.
17. Kaneshiro T.L., Lu Z.R. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 2009, 30:5660-5666.
18. Meng H., Liong M., Xia T., Li Z., Ji Z., Zink J.I., et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010, 4:4539-4550.
19. Li J.M., Wang Y.Y., Zhao M.X., Tan C.P., Li Y.Q., Le X.Y., et al. Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. Biomaterials 2012, 33:2780-2790.
20. Lee J.H., Nan A. Combination drug delivery approaches in metastatic breast cancer. J Drug Deliv 2012, 2012:915375.
21. Lo S.L., Wang S. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 2008, 29:2408-2414.
22. Varkouhi A.K., Scholte M., Storm G., Haisma H.J. Endosomal escape pathways for delivery of biologicals. J Control Release 2011, 151:220-228.
23. Madani F., Lindberg S., Langel U., Futaki S., Graslund A. Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys 2011, 2011:414729.
24. Andaloussi S.E., Lehto T., Mager I., Rosenthal-Aizman K., Oprea I.I., Simonson O.E., et al. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res 2011, 39:3972-3987.
25. Sethuraman V.A., Lee M.C., Bae Y.H. A biodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm Res 2008, 25:657-666.
26. Vives E., Schmidt J., Pelegrin A. Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 2008, 1786:126-138.
27. Kang S.I., Na K., Bae Y.H. Sulfonamide-containing polymers: a new class of pH-sensitive polymers and gels. Macromol Symp 2001, 172:149-156.
28. Lee E.S., Gao Z., Bae Y.H. Recent progress in tumor pH targeting nanotechnology. J Control Release 2008, 132:164-170.
29. Sethuraman V.A., Na K., Bae Y.H. pH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study. Biomacromolecules 2006, 7:64-70.
30. Yamashita M., Kajiyama H., Terauchi M., Shibata K., Ino K., Nawa A., et al. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo. Int J Cancer 2007, 120:2243-2250.
31. Dixon J., Kaklamanis L., Turley H., Hickson I.D., Leek R.D., Harris A.L., et al. Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol 1994, 47:43-47.
32. Liu D., Liu F., Liu Z., Wang L., Zhang N. Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol Pharm 2011, 8:2291-2301.
33. Son S., Singha K., Kim W.J. Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier. Biomaterials 2010, 31:6344-6354.
34. Liu C., Yu W., Chen Z., Zhang J., Zhang N. cNGR conjugated poly(lactic acid)-poly(ethylene glycol) nanoparticles for targeted gene delivery. J Control Release 2011, 152(Suppl. 1):e155-e157.
35. Xin H., Sha X., Jiang X., Chen L., Law K., Gu J., et al. The brain targeting mechanism of angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles. Biomaterials 2012, 33:1673-1681.
36. Jaiswal R., Panda D. Cysteine 155 plays an important role in the assembly of Mycobacterium tuberculosis FtsZ. Protein Sci 2008, 17:846-854.
37. Lai P.S., Lou P.J., Peng C.L., Pai C.L., Yen W.N., Huang M.Y., et al. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J Control Release 2007, 122:39-46.
38. Rihova B., Etrych T., Pechar M., Jelinkova M., Stastny M., Hovorka O., et al. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. J Control Release 2001, 74:225-232.
39. He J., Liu G., Dou S., Gupta S., Rusckowski M., Hnatowich D. An improved method for covalently conjugating morpholino oligomers to antitumor antibodies. Bioconjug Chem 2007, 18:983-988.
40. Wu C.C., Hayashi T., Takabayashi K., Sabet M., Smee D.F., Guiney D.D., et al. Immunotherapeutic activity of a conjugate of a toll-like receptor 7 ligand. Proc Natl Acad Sci U S A 2007, 104:3990-3995.
41. Kozlov I.A., Melnyk P.C., Stromsborg K.E., Chee M.S., Barker D.L., Zhao C. Efficient strategies for the conjugation of oligonucleotides to antibodies enabling highly sensitive protein detection. Biopolymers 2004, 73:621-630.
42. Guo M., Yan Y., Liu X., Yan H., Liu K., Zhang H., et al. Multilayer nanoparticles with a magnetite core and a polycation inner shell as pH-responsive carriers for drug delivery. Nanoscale 2010, 2:434-441.
43. Intra J., Salem A.K. Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo. J Control Release 2008, 130:129-138.
44. Akinc A., Thomas M., Klibanov A.M., Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005, 7:657-663.
45. Lu D., Wen X., Liang J., Gu Z., Zhang X., Fan Y. A pH-sensitive nano drug delivery system derived from pullulan/doxorubicin conjugate. J Biomed Mater Res B Appl Biomater 2009, 89:177-183.
46. Luo X., Feng M., Pan S., Wen Y., Zhang W., Wu C. Charge shielding effects on gene delivery of polyethylenimine/DNA complexes: PEGylation and phospholipid coating. J Mater Sci Mater Med 2012, 23:1685-1695.
47. Ulasov A.V., Khramtsov Y.V., Trusov G.A., Rosenkranz A.A., Sverdlov E.D., Sobolev A.S. Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy. Mol Ther 2011, 19:103-112.
48. Gaumet M., Vargas A., Gurny R., Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008, 69:1-9.
49. 3+ up-converting phosphor nanoparticles. Chem Mater 2010, 22:311-318.
50. Rettig W.J., Garin-Chesa P., Healey J.H., Su S.L., Jaffe E.A., Old L.J. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci U S A 1992, 89:10832-10836.
51. Auerbach R., Akhtar N., Lewis R.L., Shinners B.L. Angiogenesis assays: problems and pitfalls. Cancer Metastasis Rev 2000, 19:167-172.
52. Vag T., Schramm T., Kaiser W.A., Hilger I. Proliferating and quiescent human umbilical vein endothelial cells (HUVECs): a potential in vitro model to evaluate contrast agents for molecular imaging of angiogenesis. Contrast Media Mol Imaging 2009, 4:192-198.
53. Komarova Y., Malik A.B. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 2010, 72:463-493.
54. Schnitzer J.E. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev 2001, 49:265-280.
55. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2003, 422:37-44.
56. Sorkin A., Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol 2002, 3:600-614.